PMID: Biol Trace Elem Res. 2019 Oct 25. Epub 2019 Oct 25. PMID: 31654258 Abstract Title: Curcumin and Selenium Prevent Lipopolysaccharide/Diclofenac-Induced Liver Injury by Suppressing Inflammation and Oxidative Stress. Abstract: Diclofenac (DCL), an anti-inflammatory drug used to reduce pain and inflammation, ranks in the top causes of drug-induced liver injury. The inflammatory stress induced by …
Category Archives: Uncategorized
Selenium supplementation can delay CD4 decline in HIV-infected patients.
PMID: Clin Nutr ESPEN. 2019 Dec ;34:1-7. Epub 2019 Oct 3. PMID: 31677697 Abstract Title: Selenium supplementation in HIV-infected individuals: A systematic review of randomized controlled trials. Abstract: BACKGROUND & AIM: HIV infection has been linked to selenium deficiency which, in turn, is thought to be associated with a high risk of tuberculosis and mortality …
Continue reading “Selenium supplementation can delay CD4 decline in HIV-infected patients.”
Neuroprotective mechanisms of selenium against arsenic-induced behavioral impairments in rats.
PMID: Neurotoxicology. 2019 Oct 31 ;76:99-110. Epub 2019 Oct 31. PMID: 31678059 Abstract Title: Neuroprotective mechanisms of selenium against arsenic-induced behavioral impairments in rats. Abstract: Environmental pollution due to arsenic is associated with several adverse health effects including neurotoxicity in animals and humans. Selenium is a nutritionally essential trace metalloid well documented to elicit compelling …
Lower circulating zinc and selenium levels might be associated with an increased risk of asthma.
PMID: Public Health Nutr. 2019 Nov 5:1-8. Epub 2019 Nov 5. PMID: 31685060 Abstract Title: Lower circulating zinc and selenium levels are associated with an increased risk of asthma: evidence from a meta-analysis. Abstract: OBJECTIVE: Previous studies evaluating the associations of circulating Zn and Se levels with asthma have produced inconsistent results. Therefore, we conducted …
Potential therapeutic targets of quercetin and its derivatives: its role in the therapy of cognitive impairment.
PMID: J Clin Med. 2019 Oct 25 ;8(11). Epub 2019 Oct 25. PMID: 31717708 Abstract Title: Potential Therapeutic Targets of Quercetin and Its Derivatives: Its Role in the Therapy of Cognitive Impairment. Abstract: Quercetin (QC) is a flavonoid and crucial bioactive compound found in a variety of vegetables and fruits. In preclinical studies, QC has …
The therapeutic potential of quercetin in Parkinson’s disease.
PMID: Curr Drug Targets. 2019 Nov 12. Epub 2019 Nov 12. PMID: 31721700 Abstract Title: The therapeutic potential of quercetin in Parkinson's disease: Insights into its molecular and cellular regulation. Abstract: Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive death of dopaminergic neurons in the substantia nigra pars compacta …
Continue reading “The therapeutic potential of quercetin in Parkinson’s disease.”
The anti-staphylococcal potential of ethanolic polish propolis extracts.
PMID: Molecules. 2019 May 3 ;24(9). Epub 2019 May 3. PMID: 31058881 Abstract Title: The Anti-Staphylococcal Potential of Ethanolic Polish Propolis Extracts. Abstract: The principal objective of this study was to determine the anti-staphylococcal potential of ethanol extracts of propolis (EEPs). A total of 20 samples of propolis collected from apiaries located in different regions …
Continue reading “The anti-staphylococcal potential of ethanolic polish propolis extracts.”
Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia.
PMID: J Cell Physiol. 2019 Aug ;234(10):17392-17404. Epub 2019 Feb 20. PMID: 30790292 Abstract Title: Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia. Abstract: Microenvironmental hypoxia-mediated drug resistance is responsible for the failure of cancer therapy. To date, the role of the hedgehog pathway in resistance …
Long-term exposure to oroxylin A inhibits metastasis by suppressing CCL2 in oral squamous cell carcinoma cells.
PMID: Cancers (Basel). 2019 Mar 12 ;11(3). Epub 2019 Mar 12. PMID: 30871117 Abstract Title: Long-Term Exposure to Oroxylin A Inhibits Metastasis by Suppressing CCL2 in Oral Squamous Cell Carcinoma Cells. Abstract: Oroxylin A (Oro-A), the main bioactive flavonoid extracted from, has been reported to inhibit migration in various human cancer cell models. In this …
Oroxylin A could be a therapeutic potential candidate for the treatment of breast cancer.
PMID: Biomed Res Int. 2019 ;2019:9241769. Epub 2019 Jun 23. PMID: 31341911 Abstract Title: Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-B Signaling Pathway in Human Breast Cancer Cells. Abstract: Oroxylin A is a natural extract and has been reported to have a remarkable anticancer function. However, the mechanism of its anticancer …
Health Time 